» Articles » PMID: 17156898

Synthesis and Antimicrobial Activities of Some Novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines Carrying Thioalkyl and Sulphonyl Phenoxy Moieties

Overview
Journal Eur J Med Chem
Specialty Chemistry
Date 2006 Dec 13
PMID 17156898
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Thirty one new 6-aryl-3-{(4-substituted phenoxy) methyl}-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles (6a-s) and 6-aryl-3-[(4-substituted phenoxy methyl]-7H-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines (7a-l) have been synthesized from 4-thioalkyl phenols (1a-b) through a multi-step reaction sequence. Compounds 1a-b reacted with ethyl chloroacetate in presence of acetone and potassium carbonate to give ethyl [4-(thioalkyl) phenoxy] acetates (2a-b). Further, 2a was oxidized to [4-(methyl sulphonyl) phenoxy] acetate (2c) using hydrogen peroxide in acetic acid. Reactions of (2a-c) with hydrazine hydrate in alcoholic medium furnished 2-[4-thiosubstituted phenoxy] acetohydrazides (3a-b) and 2-[4-methyl sulphonyl phenoxy] acetohydrazide (3c) which on treatment with carbon disulphide and methanolic potassium hydroxide yielded corresponding potassium dithiocarbazates (4a-c). They were then converted to 4-amino-5-[(4-thioalkyl phenoxy) methyl]-4H-1,2,4-triazole-3-thiols (5a-b) and 4-amino-5-[(4-methyl sulphonyl phenoxy) methyl]-4H-1,2,4-triazole-3-thiol (5c) by refluxing them with aqueous hydrazine hydrate. The title compounds 6a-s were prepared by condensing 5a-c with various aromatic carboxylic acids in presence of phosphorus oxychloride. The intermediates 5a-c, on condensation with various substituted phenacyl bromides afforded a series of title compounds (7a-l). The structures of new compounds 2a-7l were established on the basis of their elemental analysis, IR, (1)H NMR, (13)C NMR and mass spectral data. All the title compounds were subjected to in vitro antibacterial testing against four pathogenic strains and antifungal screening against three fungi. Preliminary results indicate that some of them exhibited promising activities and they deserve more consideration as potential antimicrobials.

Citing Articles

Antimicrobial Potency and β-Carbonic Anhydrase Inhibition Efficacy of Phenazone-Based Molecules.

Rashdan H, El-Sayyad G, Shehadi I, Abdelmonsef A Molecules. 2023; 28(22).

PMID: 38005213 PMC: 10672871. DOI: 10.3390/molecules28227491.


Novel [1,2,4]triazolo[3,4-][1,3,4]thiadiazine and [1,2,4]triazolo[3,4-][1,3,4]thiadiazepine Derivatives: Synthesis, Anti-Viral In Vitro Study and Target Validation Activity.

Khramchikhin A, Skrylnikova M, Esaulkova I, Sinegubova E, Zarubaev V, Gureev M Molecules. 2022; 27(22).

PMID: 36432042 PMC: 9694146. DOI: 10.3390/molecules27227940.


Vision on Synthetic and Medicinal Facets of 1,2,4-Triazolo[3,4-b][1,3,4]thiadiazine Scaffold.

Aggarwal R, Hooda M, Kumar P, Sumran G Top Curr Chem (Cham). 2022; 380(2):10.

PMID: 35122161 PMC: 8816708. DOI: 10.1007/s41061-022-00365-x.


Optimized Synthesis of New Thiosemicarbazide Derivatives with Tuberculostatic Activity.

Popovici C, Pavel C, Sunel V, Cheptea C, Dimitriu D, Dorohoi D Int J Mol Sci. 2021; 22(22).

PMID: 34830021 PMC: 8622382. DOI: 10.3390/ijms222212139.


Anticancer Activity of Triazolo-Thiadiazole Derivatives and Inhibition of AKT1 and AKT2 Activation.

Trafalis D, Sagredou S, Dalezis P, Voura M, Fountoulaki S, Nikoleousakos N Pharmaceutics. 2021; 13(4).

PMID: 33916378 PMC: 8066331. DOI: 10.3390/pharmaceutics13040493.